Canabrex 300 mg by Theralogix

If nerve-related pain is the problem—sciatica, carpal tunnel, post-surgical nerve irritation, pelvic pain, or lingering muscle tenderness—palmitoylethanolamide (PEA) is worth a trial. It’s non‑psychoactive and can be a next step if NSAIDs upset your stomach or if gabapentin makes you groggy. The twice-daily 300 mg here (600 mg/day) is a practical starting dose. Expect the biggest upside in neuropathic pain; joint arthritis can respond too, even when hs-CRP (a blood inflammation marker) looks normal.

PEA is a fatty compound your body makes that calms overactive mast cells (the immune cells that release histamine) and microglia (the brain and nerve immune cells that amplify pain). It activates PPAR-α (a receptor that turns down inflammatory gene signaling) and indirectly balances the endocannabinoid system without binding cannabis receptors, so there’s no high. In responders, this shows up as lower pain sensitivity over 2–8 weeks, with modest or no change in hs-CRP.

Take one 300 mg capsule with breakfast and one with dinner, with food. Most trials start at 600 mg/day; if pain relief is partial after 2–4 weeks, clinicians sometimes increase to 900–1,200 mg/day short term. Benefits are usually felt within 2–8 weeks. Micronized or ultramicronized PEA absorbs better; this dose works well for maintenance once symptoms settle.

PEA is well tolerated, but skip it during pregnancy or breastfeeding due to limited safety data. Use caution with severe liver or kidney disease, and review excipients if you have soy or peanut allergy. It plays well with NSAIDs, acetaminophen, SNRIs, or gabapentin, but don’t use it as your only plan for new, severe, or worsening pain—get evaluated.